General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0RWTUE
ADC Name
hCD46-29
Synonyms
hCD46 29
   Click to Show/Hide
Drug Status
Investigative
Indication
In total 1 Indication(s)
Uterine sarcoma [ICD11:2C72]
Investigative
Antibody Name
Anti-CD46 mAb
 Antibody Info 
Antigen Name
Membrane cofactor protein (CD46)
 Antigen Info 
Payload Name
PNU-159682
 Payload Info 
Therapeutic Target
DNA topoisomerase 2-alpha (TOP2A)
 Target Info 
Linker Name
PNU-thiazole cleavable linker 29
 Linker Info 
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal Effective Concentration (EC50) 
41
pM
MES-SA cells
Uterine sarcoma
Half Maximal Effective Concentration (EC50) 
1.6
nM
HEK293T cells
Normal
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) 41.00 pM Positive CD46 expression (CD46 +++/++)
Method Description
Cells were seeded at 5000 per well in a 96-well plate in complete RPMI 1640. Antibody-ZAP complexes (Advanced Targeting Systems; produced according to manufacturer's instructions) or ADCs were added to the cells and plates incubated for 72 hours and 5% carbon dioxide.
In Vitro Model Uterine sarcoma MES-SA cells CVCL_1404
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) 1.60 nM Positive CD46 expression (CD46 +++/++)
Method Description
Cells were seeded at 5000 per well in a 96-well plate in complete RPMI 1640. Antibody-ZAP complexes (Advanced Targeting Systems; produced according to manufacturer's instructions) or ADCs were added to the cells and plates incubated for 72 hours and 5% carbon dioxide.
In Vitro Model Normal HEK293T cells CVCL_0063
References
Ref 1 Evaluation of PNU-159682 antibody drug conjugates (ADCs). Bioorg Med Chem Lett. 2020 Dec 15;30(24):127640. doi: 10.1016/j.bmcl.2020.127640. Epub 2020 Oct 28.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.